Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-04-003911
Filing Date
2004-08-10
Accepted
2004-08-10 15:38:38
Documents
8
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 MATRITECH, INC. 10-Q b51121mie10vq.htm 10-Q 335649
2 EX-3.5 CERTIFICATE OF AMENDMENT b51121miexv3w5.txt EX-3.5 3295
3 EX-10.1 SECOND AMENDMENT TO AGREEMENT OF LEASE b51121miexv10w1.txt EX-10.1 10061
4 EX-10.3 2002 EMPLOYEE STOCK PURCHASE PLAN b51121miexv10w3.txt EX-10.3 27095
5 EX-31.1 SECTION 302 CEO CERTIFICATION b51121miexv31w1.txt EX-31.1 4086
6 EX-31.2 SECTION 302 CFO CERTIFICATION b51121miexv31w2.txt EX-31.2 4095
7 EX-32.1 SECTION 906 CEO CERTIFICATION b51121miexv32w1.txt EX-32.1 1242
8 EX-32.2 SECTION 906 CFO CERTIFICATION b51121miexv32w2.txt EX-32.2 1250
  Complete submission text file 0000950135-04-003911.txt   389269
Mailing Address 330 NEVADA STREET NEWTON MA 02160-1458
Business Address 330 NEVADA ST NEWTON MA 02160 6176616660
MATRITECH INC/DE/ (Filer) CIK: 0000884847 (see all company filings)

EIN.: 042985132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12128 | Film No.: 04964449
SIC: 2835 In Vitro & In Vivo Diagnostic Substances